← All medicines
Pandemic influenza vaccine H5N1 AstraZeneca nasal spray, suspension. Pandemic influenza vaccine (H5N1) (live attenuated, nasal).
Licence EU/1/16/1089/001 · Unknown
- Licence holder
- AstraZeneca AB (all products →)
- Active substance
- Strain. a/vietnam/1203/2004 (h5n1) strain (live attenuated)
- Dosage form
- Nasal spray, suspension
- Route of administration
- Nasal use
- ATC codes
- J07BB, J07BB03
- First authorised
- 20/05/2016
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.